Temazepam Facts
Depressant;
Description
Temazepam is a synthetic depressant of the benzodiazepine class. It amplifies GABA — the brain's main inhibitory signaling system — slowing neural activity to produce sedation and sleep.[1]
Subjective effects include sedation, anxiety relief, muscle relaxation, and anterograde amnesia — impaired ability to form new memories while the drug is active. The experience is one of gradual, enveloping heaviness: a warm cognitive dimming and physical loosening that builds steadily toward sleep.
Temazepam produces physical dependence with regular use, and tolerance to its sleep-promoting effect builds within two to three weeks of nightly dosing.[2][3] Alone, it is rarely fatal — but combining it with opioids or alcohol dramatically raises the risk of fatal stopped breathing.[4]
Dose and durationby route · individual sensitivity varies
Starts in 30 – 60 minLasts 7 – 8 hoursAfter-effects 3.5 – 18.4 hours
Body and dependence
- Acute toxicity
- Low
- Chronic toxicity
- Moderate
- Physical dependence
- High
- Psychological dependence
- Moderate
- Withdrawal
- Severe · medical supervision
- Compulsive redosing
- Moderate
Tolerance
- Builds
- Moderate
- Fully resets after
- 10.5 days
- Carries over to
- benzodiazepines;
barbiturates; zolpidem; zopiclone; zaleplon; alcohol
Effectslikely at a common dose
- Perception
- Dreaming suppression;
+4 possible, including Spatial disorientation, Visual acuity suppression, Vestibular distortion - Body
- Sedation;
Muscle relaxation; Motor control impairment; Bodily heaviness; Physical fatigue; +7 possible, including Dizziness, Respiratory depression, Nystagmus (eye wobbles) - Thinking
- Analysis suppression;
Cognitive impairment; Decision impairment; Focus suppression; +14 possible, including Language suppression, Memory suppression, Information processing suppression - Feeling
- Anxiety suppression;
+3 possible, including Emotional lability - Self
- none likely · 6 possible, including Communication suppression, Craving
- Time
- none likely · 2 possible, including Temporal disorientation
Who shouldn't take it
Combinations60 recorded
Seek help immediately if
- Extreme drowsiness — can't stay awake or be roused
- Confusion, slurred speech, severe loss of coordination
- Slow, shallow, or irregular breathing
- Unconsciousness / unresponsive; limp, floppy body
- Blue lips or fingertips
- Vomiting while sedated (choking / aspiration risk)
- Cold, clammy skin; weak pulse
What to do
- Try to wake them — shout, firm sternal rub
- If unresponsive or breathing is impaired, call emergency services
- Place them in the recovery position — critical, they can choke on vomit
- Monitor breathing continuously; be ready to give rescue breaths / CPR
- Never leave them alone to "sleep it off"
- Do not give other drugs, stimulants, or more depressants
Most depressant overdoses resolve with airway protection, breathing support, and monitoring. The danger is respiratory depression and choking on vomit — sharply worse when combined with opioids or alcohol. GHB/GBL overdoses often involve sudden deep unconsciousness and may self-resolve, but airway protection is essential.
988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE
References
- [1]
- [2]^Kales A, Bixler EO, Soldatos CR, et al. (1986) Quazepam and temazepam: effects of short- and intermediate-term use and withdrawal — Clinical pharmacology and therapeutics PMID:2868823
- [3]^Lader M (1994) Anxiolytic drugs: dependence, addiction and abuse — European neuropsychopharmacology PMID:7919947
- [4]^Gudin JA, Mogali S, Jones JD, Comer SD (2013) Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use — Postgraduate medicine doi:10.3810/pgm.2013.07.2684